New Guidelines to Evaluate the Response to Treatment in Solid Tumors -
P Therasse, SG Arbuck, EA Eisenhauer, J Wanders, … - jnci, 2000 - jnci.oxfordjournals.org
... Anticancer cytotoxic agents go through a process by which their antitumor ... After several
years of intensive discussions, a new set of guidelines is ready ...
… Crisis. New NCI Policies for Handling the Large-Scale Production of Novel Natural Product Anticancer … -
GM Cragg, SA Schepartz, M Suffness, MR Grever - Journal of Natural Products, 1993 - pubs.acs.org
... in the complete clinical evaluation of an anticancer agent at ... 7) showed that this
new drug produced ... Likewise, recommendations of the natural product experts to ...
Clinical Trial Designs for Cytostatic Agents: Are New Approaches Needed? -
EL Korn, SG Arbuck, JM Pluda, R Simon, RS Kaplan, … - Journal of Clinical Oncology, 2001 - jco.ascopubs.org
... Eisenhauer EA, Harris AL, et al: Anticancer agents targeting ... New York, NY, Marcel
Dekker, 1998, pp 539-550; ... and II trials of novel anti-cancer agents: Endpoints ...
Funding New Cancer Drugs in Ontario: Closing the Loop in the Practice Guidelines Development Cycle -
JL Pater, GP Browman, MC Brouwers, MF Nefsky, WK … - Journal of Clinical Oncology, 2001 - jco.ascopubs.org
... was licensing more and more new anticancer agents. ... was given the responsibility to
implement its recommendations. Briefly, the key recommendation that has been ...
3'-Deoxy-3'-[18F] Fluorothymidine as a New Marker for Monitoring Tumor Response to Antiproliferative … -
H Barthel, MC Cleij, DR Collingridge, OC … - Cancer Research, 2003 - AACR
... Moore MJ, Erlichmann C. Pharmacology of anticancer drugs Tannock ... 370-391,
McGraw-Hill New York 1998 ... emission tomography: review and 1999 EORTC recommendations. ...
Quality of Informed Consent: a New Measure of Understanding Among Research Subjects -
S Joffe, EF Cook, PD Cleary, JW Clark, JC Weeks - jnci, 2001 - jnci.oxfordjournals.org
... (34), and on the recommendations of the ... M. Statistical and ethical issues in the
design and conduct of phase I and II clinical trials of new anticancer agents. ...
Thalidomide: a new anticancer drug? -
M Fanelli, R Sarmiento, D Gattuso, G Carillio, B … - eid, 2003 - Expert Opinion
... and conclusions For reprint orders, please contact: reprints@ashley-pub.com
Thalidomide: a new anticancer drug? Massimo Fanelli, Roberta ...
Improving the evaluation of new cancer treatments: challenges and opportunities -
ML Rothenberg, DP Carbone, DH Johnson - cancer. J, 2001 - chem.missouri.edu
... RA, Cokkinides, V. & Eyre, HJ American Cancer Society guidelines for the ... development
and approval is slowing ? since 2000, only five new anticancer agents ...
Tumour lysis syndrome: new therapeutic strategies and classification -
MS Cairo, M Bishop - British Journal of Haematology, 2004 - Blackwell Synergy
... Recommended guidelines to prevent and/or treat hyperuricaemia. ... The New England Journal
of Medicine, 289, 1335 ... Expert Review of Anticancer Therapy 7:2, 233. Amy R ...
Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor a A NEW MODEL FOR ANTI- … -
RA Campbell, P Bhat-Nakshatri, NM Patel, D … - Journal of Biological Chemistry, 2001 - ASBMB
... and -tubulin (Sigma) was performed as per manufacturer's recommendations. ... in this
window] [in a new window], Fig. ... 4. Johnston, SR (1997) Anticancer Drugs 8, 911 ...
Source: Google Scholar |